Empyema due to Bordetella pertussis in an Adult Patient With Lung Cancer

Şentürk, Ekrem; Sen, Sayan; Telli, Murat

doi:10.1016/j.arbr.2012.04.002

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alcoholism is an ongoing national healthcare crisis with reported 15 million people ages 12 and older meeting criteria for Alcohol Use Disorder according to the 2019 National Survey on Drug Use and Health [ 10 ]. Recently, there have been several reported human cases of B. bronchiseptica infections with risk factors including COVID-19, HIV, lung malignancy and decompensated liver cirrhosis; however, we only found 2 previous case reports of B. bronchiseptica infections with the primary immunocompromising risk factor being related to alcohol use [ 3 , 5 , 9 , 11 , 13 ]. Additionally, a recent case report describes a pig farmer that contracted B. bronchiseptica [ 2 ] .…”

Section: Discussionmentioning

confidence: 78%

Bordetella bronchiseptica empyema in patient with chronic alcohol use disorder

Williams

Chao

Fakess

et al. 2022

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 78%

Bordetella bronchiseptica empyema in patient with chronic alcohol use disorder

Williams

Chao

Fakess

et al. 2022

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

“…[24][25][26] Five other cases have been cited in the literature of pertussis in patients with cancer and a mix of hematological malignancies and solid tumors (Table). 15,[27][28][29][30] It is worthy of note that these cases were published prior the advent of PCR assay and several were based on culture of the organism from extrapulmonary sources (eg, blood, empyema fluid). 15,[27][28][29][30] The recommended antimicrobial agents for the treatment or chemoprophylaxis of pertussis in patients who are immunocompromised or immunocompetent are azithromycin, clarithromycin, and erythromycin.…”

Section: Discussionmentioning

confidence: 99%

Bordetella pertussis Infection in Patients with Cancer

Yacoub

Nanjappa²,

Janz³

et al. 2016

Cancer Control

View full text Add to dashboard Cite

We illustrate 2 cases of pneumonia associated with Bordetella pertussis infection in 72-year-old and 61-year-old patients with cancer receiving myelosuppressive therapy after hematopoietic stem cell transplantation. Bacterial infections are a significant cause of morbidity and mortality in patients with cancer, and those receiving hematopoietic stem cell transplant, solid organ transplant, or myelosuppressive therapy are at increased risk. The infection was detected and the 2 patients had good outcomes following azithromycin treatment. Pertussis, also known as whooping cough, is a contagious respiratory illness that has become a public health challenge due to decreased immunity of the pertussis vaccine. Therefore, it is critical to recognize pertussis early in the course of the disease.

show abstract

“…Rare but serious complications can include pneumonia, encephalopathy, and seizures have been reported, 43 and immunocompromised patients are vulnerable to serious, often fatal, complications. 44 Moreover, in recent years, there has been a considerable increase in the cases of pertussis, with reports from California in 2010 of over 9,000 cases and 10 infant deaths. 45 The evaluation of serological evidence of immunity in patients with cancer has demonstrated a waning of immunity for Tetanus, diphtheria and acellular pertussis (Tdap) after chemotherapy.…”

Section: Pneumococcal Vaccinementioning

confidence: 99%